This week addressed AI accountability, CPHI award winners, NFC anticounterfeiting, first-in-class FDA approvals, and a shelved FDA voucher pilot lead this week’s roundup.
|Articles|November 2, 2018
- Pharmaceutical Technology-11-02-2018
- Volume 42
- Issue 11
Custom Multi-Shaft Mixer
Ross, Charles & Son added a custom 150-gallon Triple Shaft Mixer, the Ross VersaMix Model VMC-150, with elaborate automation and safety functions.
Advertisement
Charles Ross & Son Company has customized 150-gallon Triple Shaft Mixer, the Ross VersaMix Model VMC-150, with elaborate automation and safety functions.
Features include six pneumatic clamps rated for 4000 lbs each for remote locking of the mix vessel cover, which is designed for 29.5-in. Hg vacuum and 5-psi internal pressure.
The mixer also includes automated valves for powder feed and clean-in-place liquids, a resistance-temperature detecting multi-point temperature sensor, built-in vacuum pump assembly, load cell system, and a centralized human machine interface. The VMC-150 features a helical auger screw for submerging floating agglomerates. When reversed, the auger screw surfaces air pockets resulting in decreased batch cycle time.
Articles in this issue
about 8 years ago
Guidelines on Integral Drug-Device Combinationsabout 8 years ago
Detachable AODD Pumpabout 8 years ago
Advanced Paddle Blender for Labsabout 8 years ago
Bioimaging Molecular Probesabout 8 years ago
User Requirements Specifications–How Difficult Can It Be?about 8 years ago
Single-Use Bioprocessing Equipment Trends and Adoption by CMOsabout 8 years ago
Innovations in Prefilled Syringes for Biologic Drugsabout 8 years ago
Media Requirements for Different Cell SourcesAdvertisement
Related to this article
Cole and Jaenisch explain why defending against AI poisoning in pharma manufacturing calls for a data steward role, immutable instruction ledgers, and automation.
Gloveless isolators don’t end interventions. Learn to assess intervention dependency in robotic aseptic filling and when glove ports are justified.
Terry Katz, CEO and co-founder of ForgeStop Technology Corporation, explains how the company’s product is worth the investment by protecting products and patients.
The FDA has shelved its National Priority Voucher pilot, leaving sponsors that built CMC and launch-readiness plans around 1- to 2-month reviews facing uncertain timelines.
Regulators will test pharma companies against their own internal AI policies. Jaenisch, Muraru, and Pandey explain how to build defensible, inspection-ready AI practices.
Terry Katz, CEO and co-founder of ForgeStop Technology Corporation, explains how its connected technology can enhance anticounterfeiting and how data are handled within the product.
Celtic Renewables won the CPHI Award for Sustainable Pharma Excellence for its green chemicals used in pharmaceutical manufacturing. Bettina Brierley, chief commercial officer, talks about the adoption, capacity, and pricing of biosolvents.
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
France Remains One of Europe’s Leading Biotech Funding Hubs
2
CPHI Pharma Award Winner: Drug Delivery, Devices, & Packaging
3
Signs Point to FDA Shelving Priority Voucher Pilot, Stalling Fast-Track Drug Reviews
4
Investing in Protecting Pharma Products
5